A Randomized Double-Blind Placebo-Controlled Phase IIB Trial of Curcumin in Oral Leukoplakia-Reference-Cited by-同舟云学术

A Randomized Double-Blind Placebo-Controlled Phase IIB Trial of Curcumin in Oral Leukoplakia

Published:2016-06-07 Issue:8 Volume:9 Page:683-691
ISSN:1940-6207
Container-title:Cancer Prevention Research
language:en
Short-container-title:Cancer Prev Res

Author:

Kuriakose Moni Abraham,Ramdas Kunnambath,Dey Bindu,Iyer Subramanya,Rajan Gunaseelan,Elango Kalavathy K.,Suresh Amritha,Ravindran Divya,Kumar Rajneesh R.,R Prathiba,Ramachandran Surya,Kumar Nisha Asok,Thomas Gigi,Somanathan Thara,Ravindran Hiran K.,Ranganathan Kannan,Katakam Sudhakar Babu,Parashuram Shivashankar,Jayaprakash Vijayvel,Pillai M. Radhakrishna

Funder

Department of Biotechnology

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Cancer Properties of Two Intravenously Administrable Curcumin Formulations as Evaluated in the 3D Patient-Derived Cancer Spheroid Model;International Journal of Molecular Sciences;2024-08-05

2. Folate-Modified Curcumin-Loaded Nanoparticles for Overcoming Delivery Challenges in Cancer Treatment: A Narrative Review;Current Pharmaceutical Biotechnology;2024-06-24

3. Oral Pre-malignancy: An Update on Novel Therapeutic Approaches;Current Oncology Reports;2024-06-12

4. Natural products and diet for the prevention of oral cancer: Research from south and southeast Asia;Oral Diseases;2024-05-28

5. Application and potential value of curcumin in prostate cancer: a meta-analysis based on animal models;Frontiers in Pharmacology;2024-05-09